Clinical trial
Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant…
NCT00321334 · Chinese Society of Lung Cancer, Other · Completed
Key facts
| NCT number | NCT00321334 |
|---|---|
| Title | Survival Study of Docetaxel and Carboplatin as Neo-Adjuvant Vs Adjuvant Chemotherapy in Early Stage NSLC |
| Official title | Survival Study of Neo-adjuvant Versus Adjuvant Chemotherapy With Docetaxel Combined Carboplatin in Resectable Stage IB to IIIA Non-small Lung Cancer |
| Lead sponsor | Chinese Society of Lung Cancer, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer |
| Intervention type | Procedure |
| Interventions | Chemotherapy+Surgery |
| Enrollment | 410 |
| Start date | Mar 1, 2006 |
| Primary completion | Dec 1, 2013 |
| Completion | Dec 1, 2013 |
| First posted | May 3, 2006 |
| Last update posted | Aug 6, 2014 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: